Showing results (191-200 of 157,807) with videos related to
Sort By:
Pageof 15,781
Experimental Dermatology|October 18, 2015
Keratoacanthoma: a distinct entity?Tobias Gleich, Elena Chiticariu, Marcel Huber, et al.Healthcare Management Forum|May 17, 2019
Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systemsSerena S Small, Corinne M Hohl, Ellen BalkaPharmacology|July 10, 2022
Cytotoxic Effects of the Schweinfurthin Analog 5'-Methylschweinfurthin G in Malignant Plasma CellsBarbara Manfredi, Jeffrey D Neighbors, Raymond J HohlThe Journal of Antimicrobial Chemotherapy|September 1, 1987
Fleroxacin (Ro 23-6240): activity in vitro against 355 enteropathogenic and non-fermentative gram-negative bacilli and Legionella pneumophilaP Hohl, A von Graevenitz, J Zollinger-ItenThe American Journal of Physiology|January 1, 1993
Adenosine stimulation of AMP deaminase activity in adult rat cardiac myocytesB Hu, R A Altschuld, C M HohlDermatology (Basel, Switzerland)|January 1, 1996
Meleda disease: report of two cases investigated by electron microscopyE Frenk, D Guggisberg, B Mevorah, et al.Leukemia Research|August 4, 2009
Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cellsSarah A Holstein, Huaxiang Tong, Raymond J HohlSchweizerische Medizinische Wochenschrift|April 22, 1978
[The re-emergence of human rabies in Switzerland. A case history]P Hohl, R Burger, C Vorburger, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1988
Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacinR Paganoni, C Herzog, A Braunsteiner, et al.The FEBS Journal|April 19, 2017
Split tasks of asymmetric nucleotide-binding sites in the heterodimeric ABC exporter EfrCDLea M Hürlimann, Michael Hohl, Markus A SeegerPageof 15,781